279 related articles for article (PubMed ID: 15670187)
21. [Mutational spectrum of the gene for 21-hydroxylase in the patients with congenital adrenal hyperplasia from Bashkortostan].
Akhmetova VL; Ramova ZF; Malievskiĭ OA; Khusnutdinova EK
Genetika; 2008 Oct; 44(10):1420-8. PubMed ID: 19062540
[TBL] [Abstract][Full Text] [Related]
22. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
[TBL] [Abstract][Full Text] [Related]
23. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y
J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307
[TBL] [Abstract][Full Text] [Related]
24. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: genotype-phenotype correlation].
Mendes C; Vaz Matos I; Ribeiro L; Oliveira MJ; Cardoso H; Borges T
Acta Med Port; 2015; 28(1):56-62. PubMed ID: 25817499
[TBL] [Abstract][Full Text] [Related]
25. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Finkielstain GP; Chen W; Mehta SP; Fujimura FK; Hanna RM; Van Ryzin C; McDonnell NB; Merke DP
J Clin Endocrinol Metab; 2011 Jan; 96(1):E161-72. PubMed ID: 20926536
[TBL] [Abstract][Full Text] [Related]
27. [Molecular characterization of mutations and phenotype/genotype correlation in Chinese patients with 21-hydroxylase deficiency].
Zhang B; Lu ZL; Wang Y; Tao H
Yi Chuan Xue Bao; 2004 Sep; 31(9):950-5. PubMed ID: 15493145
[TBL] [Abstract][Full Text] [Related]
28. The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia.
Dracopoulou-Vabouli M; Maniati-Christidi M; Dacou-Voutetakis C
J Clin Endocrinol Metab; 2001 Jun; 86(6):2845-8. PubMed ID: 11397897
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
[TBL] [Abstract][Full Text] [Related]
30. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
[TBL] [Abstract][Full Text] [Related]
31. Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations.
Concolino P; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2010 Aug; 48(8):1057-62. PubMed ID: 20482300
[TBL] [Abstract][Full Text] [Related]
32. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
33. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P.
Lee HH; Tsai FJ; Lee YJ; Yang YC
Mol Genet Metab; 2006 Aug; 88(4):372-7. PubMed ID: 16684614
[TBL] [Abstract][Full Text] [Related]
34. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.
Stikkelbroeck NM; Hoefsloot LH; de Wijs IJ; Otten BJ; Hermus AR; Sistermans EA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3852-9. PubMed ID: 12915679
[TBL] [Abstract][Full Text] [Related]
35. Genotype-phenotype correlation in CAH patients with severe CYP21A2 point mutations in the Republic of Macedonia.
Anastasovska V; Kocova M
J Pediatr Endocrinol Metab; 2010 Sep; 23(9):921-6. PubMed ID: 21175091
[TBL] [Abstract][Full Text] [Related]
36. Detected heterozygotes during the molecular analysis of the common CYP21A2 point mutations in Macedonian patients with congenital adrenal hyperplasia and their relatives.
Anastasovska V; Kocova M
Prilozi; 2010; 31(2):71-82. PubMed ID: 21258279
[TBL] [Abstract][Full Text] [Related]
37. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
[TBL] [Abstract][Full Text] [Related]
38. Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia.
Marques CJ; Pignatelli D; Carvalho B; Barceló J; Almeida AC; Fernandes S; Witchel SF; Sousa M; Oliveira MJ; Freitas P; Fontoura M; Carvalho D; Barros A; Carvalho F
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):505-12. PubMed ID: 19856253
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
[TBL] [Abstract][Full Text] [Related]
40. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
